ArticleCurrent oncology (Toronto, Ont.)2022

Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with Chemotherapy.

Xiaolu Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.